208 related articles for article (PubMed ID: 36254911)
1. A retrospective analysis of the incidence, outcome and factors associated with the occurrence of euglycemic ketoacidosis in diabetic patients on sodium glucose co-transporter - 2 inhibitors undergoing cardiac surgery.
Murugesan KB; Balakrishnan S; Arul A; Ramalingam S; Srinivasan M
Ann Card Anaesth; 2022; 25(4):460-465. PubMed ID: 36254911
[TBL] [Abstract][Full Text] [Related]
2. Euglycemic Ketoacidosis.
Bonora BM; Avogaro A; Fadini GP
Curr Diab Rep; 2020 May; 20(7):25. PubMed ID: 32424730
[TBL] [Abstract][Full Text] [Related]
3. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery.
Chaudhry A; Roels C; Lee J
Can J Diabetes; 2022 Dec; 46(8):843-850. PubMed ID: 36068154
[TBL] [Abstract][Full Text] [Related]
4. Missed postoperative metabolic acidosis associated with sodium-glucose transporter 2 inhibitors in cardiac surgery patients: a retrospective analysis.
Kim HA; Kim JY; Kim YH; Lee YT; Park PW
Sci Rep; 2024 Apr; 14(1):8087. PubMed ID: 38582803
[TBL] [Abstract][Full Text] [Related]
5. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence.
Mehta PB; Robinson A; Burkhardt D; Rushakoff RJ
Endocr Pract; 2022 Sep; 28(9):884-888. PubMed ID: 35753675
[TBL] [Abstract][Full Text] [Related]
6. A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes.
Lui DTW; Wu T; Au ICH; Liu X; Fung MMH; Lee CH; Fong CHY; Woo YC; Lang BHH; Tan KCB; Wong CKH
Drug Saf; 2023 Jan; 46(1):53-64. PubMed ID: 36289137
[TBL] [Abstract][Full Text] [Related]
7. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
Menghoum N; Oriot P; Hermans MP; Mariage JL
Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
[TBL] [Abstract][Full Text] [Related]
8. Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery.
Lau A; Bruce S; Wang E; Ree R; Rondi K; Chau A
Can J Anaesth; 2018 Feb; 65(2):188-193. PubMed ID: 29168157
[TBL] [Abstract][Full Text] [Related]
9. Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use.
Laursen HVB; Røikjer JB; Dal J; Jensen MH
Curr Drug Saf; 2021; 16(1):73-81. PubMed ID: 32814538
[TBL] [Abstract][Full Text] [Related]
10. An audit of the effect of SGLT2 inhibitor cessation in a pre-admission clinic before and after Australian Diabetes Society guidelines.
Fookeerah P; Law H; Ali F; Chatten K; Kim C; Cheung NW
Intern Med J; 2021 Jun; 51(6):980-983. PubMed ID: 34155765
[TBL] [Abstract][Full Text] [Related]
11. Sodium-glucose cotransport-2 inhibitor induced ketoacidosis following coronary artery bypass surgery: implications for management.
McCann M; O'Brien A; Larbalestier R; Davis T
Intern Med J; 2022 May; 52(5):876-879. PubMed ID: 35538006
[TBL] [Abstract][Full Text] [Related]
12. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study.
Silva VB; Fonseca L; Duarte DB; Puga FM; Assuncao G; Garrido S; Teixeira S; Vilaverde J; Cardoso MH
Endocr Regul; 2023 Jan; 57(1):144-151. PubMed ID: 37561831
[No Abstract] [Full Text] [Related]
14. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.
Thiruvenkatarajan V; Meyer EJ; Nanjappa N; Van Wijk RM; Jesudason D
Br J Anaesth; 2019 Jul; 123(1):27-36. PubMed ID: 31060732
[TBL] [Abstract][Full Text] [Related]
15. Diabetic ketoacidosis in patients treated with SGLT2 inhibitors: experience at a tertiary hospital.
Papanastasiou L; Glycofridi S; Gravvanis C; Skarakis N; Papadimitriou I; Kanti G; Kapsali C; Kounadi T
Hormones (Athens); 2021 Jun; 20(2):369-376. PubMed ID: 33151508
[TBL] [Abstract][Full Text] [Related]
16. Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.
Wang L; Voss EA; Weaver J; Hester L; Yuan Z; DeFalco F; Schuemie MJ; Ryan PB; Sun D; Freedman A; Alba M; Lind J; Meininger G; Berlin JA; Rosenthal N
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1620-1628. PubMed ID: 31456304
[TBL] [Abstract][Full Text] [Related]
17. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study.
Iwasaki Y; Sasabuchi Y; Horikita S; Furukawa T; Shiotsuka J; Lefor AK; Sanui M
BMC Endocr Disord; 2022 Aug; 22(1):209. PubMed ID: 35987618
[TBL] [Abstract][Full Text] [Related]
18. Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors.
Auerbach JS; Gershengorn HB; Aljure OD; Lamelas J; Patel SS; Ferreira TD; Gonzalez LA; Cabrera JL
J Cardiothorac Vasc Anesth; 2023 Jun; 37(6):956-963. PubMed ID: 36872114
[TBL] [Abstract][Full Text] [Related]
19. Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Kamoshima H; Nomoto H; Yamashita K; Takahashi Y; Tsuchida K; Kuwabara S; Miya A; Cho KY; Kameda H; Nakamura A; Atsumi T; Taneda S; Kurihara Y; Aoki S; Ono Y; Miyoshi H
Endocr J; 2022 May; 69(5):495-509. PubMed ID: 34819409
[TBL] [Abstract][Full Text] [Related]
20. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors.
Fleming N; Hamblin PS; Story D; Ekinci EI
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32302001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
